Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Q2 2023 Earnings Call Transcript August 2, 2023
Intercept Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.68 EPS, expectations were $0.56.
Operator: Hello, and thank you for standing by. Welcome to Intercept Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator...
